According to the Nepalese national guidelines, integrated screening for HIV, syphilis and hepatitis B should be offered free of charge to all pregnant women during their first antenatal visit. However, the screening uptake among pregnant women remains low in the country. Identifying factors influencing the implementation of integrated screening for HIV, syphilis, and hepatitis B is essential to increase uptake and prevent mother-to-child transmission. This study investigated the knowledge, attitude, and perceptions of pregnant women, their family members, healthcare workers and decision-makers on integrated antenatal screening. On the demand side, we conducted 26 semi-structured in-depth interviews with pregnant women, their husbands, and mothers-in-law in Kapilvastu and Kathmandu. On the supply side, we conducted 11 interviews with health workers involved in antenatal screening and local and national health system decision-makers. Data were analysed using a thematic content analysis. A combination of the social-ecological model and the WHO building blocks provided a theoretical framework for interpreting the data. The analysis showed that integrated antenatal screening for HIV, syphilis and hepatitis B in Nepal involved many stakeholders and was influenced by various factors. Barriers were mainly on the supply side, including a lack of resources, a shortage of healthcare workers and a lack of training. Husbands and in-laws also play an important role in the acceptance of screening by pregnant women, mainly in rural areas. Stigma and discrimination against people with sexually transmitted diseases were reported high in the communities, and knowledge of hepatitis B and syphilis was low. Improving integrated antenatal screening will require a multi-sectoral approach with greater engagement with communities through awareness programs and enhancement of the role of health posts. This study may be useful to inform decision-makers about the challenges and enable affecting integrated screening, to guide the design of targeted interventions to improve antenatal screening rates.

The authors have declared no competing interest.

This work was supported by UK Medical Research Council (MRC)/ Newton Fund, grant number MR/R020485/1.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study received the approval of the Nepal Health Research Council (number: s23/2022 P) and University College London Ethics Committee.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Fully anonymised transcripts are uploaded to the UCL research data repository. All transcript data will be provided on request.